Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1075E-50Tests

APC Anti-Human CD32 Antibody[IV-3]

APC Anti-Human CD32 Antibody[IV-3]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the APC Anti-Human CD32 Antibody [IV-3], a highly reliable and efficient solution for immunological research and diagnostics. This product is designed to facilitate the detection and analysis of CD32, a crucial cell surface receptor involved in various immune responses.

With a generous size of 50 tests, this antibody offers an ample supply to cater to your experimental needs. Its advanced formulation ensures consistent and reproducible results, enabling accurate interpretation and analysis of CD32 expression levels.

Crafted with utmost precision and expertise, the APC Anti-Human CD32 Antibody [IV-3] exhibits exceptional specificity and sensitivity, allowing for precise identification and quantification of CD32-positive cells. This antibody's superior performance guarantees reliable and robust outcomes, making it an indispensable tool for immunologists and researchers alike.

Furthermore, this antibody is meticulously validated and quality-controlled to meet the highest standards of excellence. Its exceptional purity and stability ensure optimal performance and longevity, providing you with a dependable reagent for your experiments.

The APC Anti-Human CD32 Antibody [IV-3] is compatible with a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into various experimental protocols, enhancing the efficiency and accuracy of your research.

Invest in the APC Anti-Human CD32 Antibody [IV-3] today and unlock the potential of your immunological investigations. With its superior performance, reliability, and compatibility, this antibody is an invaluable asset for any laboratory or diagnostic facility seeking to advance their understanding of CD32-mediated immune responses.
View full details